Holen Sie sich die Stockscreener-App
92.20
1.22%
1.11
Schlusskurs vom Vortag:
$91.09
Offen:
$91.68
24-Stunden-Volumen:
182.29K
Relative Volume:
1.51
Marktkapitalisierung:
$1.18B
Einnahmen:
$86.28M
Nettoeinkommen (Verlust:
$23.61M
KGV:
50.22
EPS:
1.8359
Netto-Cashflow:
$23.97M
1W Leistung:
-4.22%
1M Leistung:
+4.18%
6M Leistung:
-4.30%
1J Leistung:
+57.74%
1-Tages-Spanne:
$91.68
$93.36
1-Wochen-Bereich:
$89.69
$97.73
52-Wochen-Spanne:
$55.11
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
92.20 | 1.18B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
IRMD Technical Analysis & Stock Price Forecast - Intellectia AI
IRadimed Corp (IRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRADIMED CORP (IRMD) Stock Chart - ChartMill
Number of shareholders of IRadimed Corp. – DUS:46K - TradingView
Iradimed director sells $285,000 in company stock By Investing.com - Investing.com Australia
Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD) - GuruFocus
Iradimed director sells $285,000 in company stock - Investing.com UK
IRADIMED (IRMD) director sells 3,000 shares in open-market trades - Stock Titan
IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares - Stock Titan
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple - Yahoo Finance
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - The Motley Fool
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - The Legal Advocate
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
IRMD Q1 2026 Earnings: EPS Beat of 7.95% Sends Stock LowerPeak Earnings Alert - newsline.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
iRadimed (IRMD) Slips Amidst Sector Headwinds: Key Levels in FocusSweep Order Flow - The Legal Advocate
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
iRadimed Corporation (IRMD) Crushes Q1 2026 Estimates — EPS $0.49 Tops ViewsEarnings Revision Downgrade - The Legal Advocate
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
TradingKey - TradingKey
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Attention Driven Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):